PLANT CELL BIOTECHNOLOGY AND MOLECULAR BIOLOGY

Clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing and artificial intelligence (AI) are increasingly presented as a unified route to precision plant breeding. Their convergence is scientifically plausible but unevenly demonstrated. CRISPR systems can create targeted sequence changes, whereas AI can prioritise candidate genes, integrate genomic and phenomic data, optimise guide RNAs and editors, predict editing outcomes, and support iterative genotype-to-phenotype learning. This critical narrative review evaluates the evidence linking these capabilities across the crop-improvement pipeline. Literature published from 1 January 2012 to 5 June 2026 was selected through transparent searches of accessible scholarly indexes and bibliographic resources, followed by citation tracking, metadata verification and thematic appraisal. Evidence is strongest for CRISPR-mediated improvement of discrete, biologically well-characterised traits, including disease resistance, quality attributes, plant architecture and selected stress responses. AI has also achieved useful performance in phenotyping, genomic prediction and CRISPR design, but superiority over conventional statistical or rule-based approaches is not consistent across datasets, species or prediction tasks. Direct evidence for fully integrated, AI-guided CRISPR breeding programmes that deliver stable field performance remains limited. Major constraints include uncertain causal target identification, small and non-representative training datasets, poor transferability across genetic backgrounds, polyploidy, genotype-by-environment interaction, transformation and regeneration bottlenecks, incomplete detection of unintended outcomes, and heterogeneous regulation. The most defensible interpretation is therefore that AI and CRISPR are complementary components of an emerging design-build-test-learn framework rather than a mature autonomous breeding platform. Progress will depend on plant-specific benchmark datasets, prospective validation, multi-environment field trials, interoperable data standards, equitable access to transformation and computational infrastructure, and governance focused on the properties and evidence of resulting products. Their integration can accelerate precision breeding, but biological causality, experimental validation and breeding judgement remain indispensable.